On October 22, 2018, the Centre for Information Policy Leadership ("CIPL") at Hunton Andrews Kurth LLP co-hosted a workshop in Brussels on "Can GDPR Work for Health Scientific Research?" (the "Workshop") with the European Federation of Pharmaceutical Industries and Associations ("EFPIA") and the Future of Privacy Forum ("FPF") to address the challenges raised by the EU General Data Protection Regulation ("GDPR") in conducting scientific health research.
Over 100 EFPIA members, policymakers, regulators and representatives from companies participated in the full day workshop.
Cecilia Álvarez, European Data Protection Officer Lead at Pfizer, and Brendan Barnes, Director of Data Protection at EFPIA set the scene for the day's discussions by emphasizing the importance of health research in advancing science, patient welfare and public good, as well as opportunities for digital health activities in Europe. Challenges to such advancement, including the consistent application of the GDPR in the medical research sector, were also highlighted.
Two extensive sessions followed these opening remarks. The first session focused on clinical trials and featured several presentations by industry experts and a panel discussion, moderated by CIPL President Bojana Bellamy. The panel discussed, in particular, the complex regulatory framework surrounding clinical trials, the interaction between the GDPR and the Clinical Trial Regulation ("CTR"), the role of consent under both regulations and operational challenges.
The second session addressed the secondary use of data which is indispensable and of significant value for...